MIDTERM ANTIDEPRESSED NAKO Flashcards
deficiency of these substances in key
areas of the brain results in depression
biogenic amine
drug that prevents the enzyme
monoamine oxidase from breaking down norepinephrine (NE),
serotonin (5HT), and dopamine (DA), leading to increased
neurotransmitter levels in the synaptic cleft;
monoamine oxidase inhibitor (MAOI)
drug that specifically
blocks the reuptake of serotonin and increases its concentration in the
synaptic cleft
selective serotonin reuptake inhibitor (SSRI
: drug that increases both
serotonin and norepinephrine concentrations
serotonin norepinephrine inhibitors (SNRIs)
drug that blocks the reuptake of
norepinephrine and serotonin
tricyclic antidepressants (TCAs)
amine found in food that causes vasoconstriction and raises
blood pressure
tyramine
Antidepressants may be classified into four main groups:
tricyclic
antidepressants (TCAs),
monoamine oxidase inhibitors (MAOIs),
selective serotonin reuptake inhibitors (SSRIs),
serotonin norepinephrine
inhibitors (SNRIs).
reduce the reuptake of 5HT and NE into nerves.
tricyclic antidepressants
s inhibit presynaptic reuptake of the neurotransmitters 5HT and NE
TCAs
sedative effects of these drugs may make them more effective in patients
whose depression is characterized by anxiety and sleep disturbances
TCAs
If TCAs are combined with ______, the risk of
arrhythmias and hypertension is increased.
sympathomimetics or clonidine
Inhibits presynaptic reuptake of norepinephrine and serotonin; anticholinergic at CNS and peripheral receptors; sedating.
Imipramine
irreversibly inhibit
MAO, an enzyme found in nerves and other tissues
Monoamine oxidase inhibitors
causes the release of stored NE from nerve
terminals
tyramine
Treatment of patients with depression who are unresponsive
to other antidepressive therapy or in whom other antidepressive therapy
is contraindicated
Phenelzine